Paul G. Savas, Director at vTv Therapeutics Inc. (VTVT), bought 15,000 shares at $4.57 ($68K) on 2017-12-07, disclosed to the SEC on 2017-12-07.
Open-market purchase of $68k VTVT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.55 | 10,000 | $46K | 66.6% |
| 2 | $4.57 | 5,000 | $23K | 33.4% |
| Total | $4.56 avg | 15,000 | $68K | 100% |
| Filing → |
| SIGA | BUY | 2019-08-12 | $51K | — | Filing → |
| SIGA | BUY | 2018-11-19 | $28K | — | Filing → |
| SIGA | BUY | 2018-11-13 | $50K | — | Filing → |